QT-019C CAR-T therapy

QT-019C CAR-T · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QT-019C CAR-T therapy, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia [EARLY_Phase 1]

See pricing